Regeneron Reports Long-Term Phase 3 Data Showing Sustained Survival Benefits With Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma - For More Information Visit tinyurl.com/32yvnhv4 @Regeneron #CSCC #Squamous_Cell_Carcinoma #Rare_Diseases #Orphan_Drugs #Libtayo

Novartis’ Remibrutinib Delivers Comprehensive Disease Control in Phase III RMS Trials, with a Robust Safety Profile - For More Information Visit tinyurl.com/4w3syjas #RMS #Multiple_Sclerosis #Rare_Diseases #EMA #FDA #Orphan_Drugs @Novartis #Remibrutinib

Genmab’s Rina-S Demonstrates Significant Progression-Free and Overall Survival Benefits in Phase 3 Trial for Platinum-Resistant Ovarian Cancer - For More Information Visit tinyurl.com/2hmmw37c @Genmab #Ovarian_Cancer #Rare_Diseases #Orphan_Drugs #Cancer_research

Roche Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People with IgA Nephropathy (IgAN) - For More Information Visit tinyurl.com/ycxnubr5 @Roche #Rare_Diseases #IgAN #Orphan_Drugs #IgA_Nephropathy #kidney_disease

Neurocrine Biosciences Publishes Expert Perspectives on Comprehensive Assessment and Management of Hyperphagia in Prader-Willi Syndrome - For More Information Visit tinyurl.com/ysms8vax @neurocrine #Prader_Willi_Syndrome #Rare_Diseases #Orphan_Drugs #Hyperphagia

Korro Reports Best-in-Class Preclinical Data for KRRO-111 showing Potential Benefits for Lung and Liver Symptoms of Alpha-1 Antitrypsin Deficiency - For More Information Visit tinyurl.com/5y82e65n @KorroBio #AATD #Alpha_1_Antitrypsin_Deficiency #Rare_Diseases

BioNTech and Gilead Team Up to Advance Promising Pumitamig and Trodelvy Combination in Phase 3 Trial for Triple-Negative Breast Cancer - For More Information Visit tinyurl.com/y49p85rh @BioNTech_Group #TNBC @GileadSciences #Breast_Cancer #Rare_Diseases

Prilenia and Ferrer Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington's Disease - For More Information Visit tinyurl.com/bdzxfy7h @PrileniaTx @ferrerforgood #Huntington_Disease #Rare_Diseases #Orphan_Drugs

Efgartigimod Improves Mobility and Daily Function in Young Woman With Refractory LEMS After Multiple Prior Treatments - For More Information Visit tinyurl.com/5n6kv3jd @argenxglobal #LEMS #Rare_Diseases #Orphan_Drugs #Lambert_Eaton_Myasthenic_Syndrome

Savara Reports Molgramostim Improvements in Gas Transfer, Respiratory Quality of Life, and Surfactant Burden in aPAP Patients - For More Information Visit checkorphan.org/news/514703/ @SavaraPharma #aPAP #Autoimmune_Pulmonary_Alveolar_Proteinosis #Rare_Diseases